A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*Jean‐Louis Vincent, Inder Kaul, Mradul Kumar Daga et al.|Critical Care Medicine|2013Cited by 322